{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:10:08Z","timestamp":1768878608366,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":950,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1093\/annonc\/mdx071","type":"journal-article","created":{"date-parts":[[2017,2,19]],"date-time":"2017-02-19T20:06:23Z","timestamp":1487534783000},"page":"1333-1338","source":"Crossref","is-referenced-by-count":20,"title":["A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)"],"prefix":"10.1016","volume":"28","author":[{"given":"J.","family":"Shamash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-J.","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Huddart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Harland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.K.","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mazhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Birtle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vinnicombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdx071_bb0010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(00)04165-9","article-title":"Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group","volume":"357","author":"Toner","year":"2001","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdx071_bb0015","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1200\/JCO.2001.19.6.1629","volume":"19","author":"de Wit","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdx071_bb0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1200\/JCO.1995.13.2.470","article-title":"Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial","volume":"13","author":"Loehrer","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdx071_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/annonc\/mdg020","article-title":"Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours","volume":"14","author":"O'Sullivan","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdx071_bb0030","first-page":"419","article-title":"Prospective study of the pulmonary toxicity of continuously infused bleomycin","volume":"65","author":"Cooper","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/mdx071_bb0035","first-page":"2011","article-title":"Improved therapeutic index of bleomycin when administered by continuous infusion in mice","volume":"62","author":"Sikic","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/mdx071_bb0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/bjc.1995.24","article-title":"Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect","volume":"71","author":"Sleijfer","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdx071_bb0045","unstructured":"EORTC QLQ-C30 Scoring Manual. In Third edition. QL Coordinator, Quality of Lofe Unit, EORTC Data Center, Avenue E Mounier 83-B11, 1200 Brussels, Belgium 2001."},{"key":"10.1093\/annonc\/mdx071_bb0050","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.3324\/haematol.11856","article-title":"FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease\u2013a useful tool for monitoring pulmonary toxicity and disease activity","volume":"92","author":"Buchler","year":"2007","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdx071_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13139-015-0388-3","article-title":"Role of (18)F-FDG PET-CT in monitoring the cyclophosphamide induced pulmonary toxicity in patients with breast cancer - 2 case reports","volume":"50","author":"Taywade","year":"2016","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1093\/annonc\/mdx071_bb0060","first-page":"161","article-title":"Antitumor-activity and toxicity of continuous-infusion versus bolus administration of bleomycin in 2 heterotransplanted human testicular cancer cell-lines","volume":"2","author":"Bokemeyer","year":"1995","journal-title":"Oncol Rep"},{"key":"10.1093\/annonc\/mdx071_bb0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0277-5379(89)90211-3","article-title":"Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with cis-platinum, vinblastine and bleomycin: a long-term follow-up","volume":"25","author":"Hansen","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1093\/annonc\/mdx071_bb0070","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1200\/JCO.2015.64.8451","article-title":"Pulmonary function in patients with germ cell cancer treated with bleomycin, etoposide, and cisplatin","volume":"34","author":"Lauritsen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdx071_bb0075","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1200\/JCO.1997.15.5.1837","article-title":"Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group","volume":"15","author":"de Wit","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdx071_bb0080","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/annonc\/mdm062","article-title":"Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)","volume":"18","author":"Culine","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdx071_bb0085","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1259\/0007-1285-58-695-1041","article-title":"Bleomycin lung: computed tomographic observations","volume":"58","author":"Rimmer","year":"1985","journal-title":"Br J Radiol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419324159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419324159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/28\/6\/1333\/17646284\/mdx071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:19:28Z","timestamp":1624695568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419324159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0923753419324159"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdx071","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}